Title: Scrutiny on Pharmaceutical Ethics: Major Penalties for Gilead and Others due to Unlawful Conduct Recently, the pharmaceutical sector has faced significant backlash after the exposure of unethical and illegal actions by several well-known organizations. Prominent among these are Gilead Sciences, based in the U.S., and three leading pharmaceutical companies operating in Belgium—Kenvue, Haleon, and […]

Germany’s Merck KGaA Set to Purchase SpringWorks Therapeutics in $3.9 Billion Transaction In a strategic initiative aimed at enhancing its presence in oncology and rare disease therapies, German science and technology powerhouse Merck KGaA has revealed a conclusive agreement to purchase SpringWorks Therapeutics, a U.S.-based biopharmaceutical company currently in clinical stages. The deal, valued at […]

A Psychedelic Breakthrough: LSD Analogue Shows Potential Without Hallucinogenic Effects In a crucial advancement toward unlocking the therapeutic possibilities of psychedelics for mental health treatment, scientists have created a new analogue of LSD that may deliver the advantageous effects of the substance—neural regeneration and enhanced cognitive functioning—without the characteristic psychedelic “trip.” The compound, named “JRT” […]